EXPE
64
-5
SWKS
43
-5
FMC
29
-5
MCHP
32
-6
WEC
45
-5
BLK
58
-3
FITB
50
-5
URBN
24
-4
LRCX
42
-4
ORLY
60
-5
MET
44
-6
LNC
33
-10
CPB
65
11
AMGN
39
-2
HBAN
45
-3
MMC
64
-3
K
60
9
MSFT
43
-3
BAC
32
-4
ADI
51
-3
EXPE
64
-5
SWKS
43
-5
FMC
29
-5
MCHP
32
-6
WEC
45
-5
BLK
58
-3
FITB
50
-5
URBN
24
-4
LRCX
42
-4
ORLY
60
-5
MET
44
-6
LNC
33
-10
CPB
65
11
AMGN
39
-2
HBAN
45
-3
MMC
64
-3
K
60
9
MSFT
43
-3
BAC
32
-4
ADI
51
-3
Financhill
Back

Biomerica Vs. Perspective Therapeutics Industry Stock Comparison

Sell
35

BMRA
Biomerica

Last Price:
0.35
Seasonality Move:
6.7%
Sell
48

CATX
Perspective Therapeutics

Last Price:
15.26
Seasonality Move:
-11.56%
Sell
35
Biomerica (BMRA) is a Sell

Is Biomerica a Buy, Sell or Hold?

  • The current Biomerica [BMRA] share price is $0.34. The Score for BMRA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • BMRA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $15.26. The Score for CATX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BMRA Stock Price Chart

What is Biomerica's stock price today?

  • The Biomerica share price today is $0.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRA is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $15.26
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing slight buying pressure.

BMRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 40.59 Sell
Chaikin Money Flow: -196259 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.3 - 0.44) Sell
Bollinger Bands (100): (0.36 - 0.62) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.66 Buy
Relative Strength Index (14 RSI): 57.38 Buy
Chaikin Money Flow: 132968 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.6 - 15.46) Buy
Bollinger Bands (100): (11.57 - 16.07) Buy

BMRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.42 Sell
20-day SMA: 0.39 Sell
50-day SMA: 0.37 Sell
200-day SMA: 0.75 Sell
8-day EMA: 0.4 Sell
20-day EMA: 0.39 Sell
50-day EMA: 0.41 Sell
200-day EMA: 0.73 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.22 Buy
20-day SMA: 14.51 Buy
50-day SMA: 13.03 Buy
200-day SMA: 10.73 Buy
8-day EMA: 15.15 Buy
20-day EMA: 14.59 Buy
50-day EMA: 13.72 Buy
200-day EMA: 11.22 Buy

Biomerica Earnings Growth & BMRA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.

Biomerica Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):